Back to search

Article

Comparing Clinical Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with T1 High Grade Bladder Cancer

2023-09-15

Abstract excerpt

<title>Abstract</title> <p>Purpose: The aim of our study is to clarify the clinical efficacy between two different Bacillus Calmette-Guérin (BCG) strains, TICE strain (Oncotice) and Connaught strain (ImmuCyst) as first line intravesical instillation therapy in patients with T1 high grade bladder urothelial cell carcinoma. <h4>Methods:</h4> Between 2008 to 2022, patients with new diagnosed T1 high-grade bladder ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d69d3ab7-69fa-5311-b80b-4e8f9876492b
DOI
10.21203/rs.3.rs-3334543/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparing Clinical Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with T1 High Grade Bladder CancerDOI 10.21203/rs.3.rs-3334543/v1
Comparison of intravesical instillation of Bacille Calmette-Guérin and epirubicin: a randomized controlled trialSemantic proximity
Bacillus Calmette–Guérin strain differences as the basis for immunotherapies against bladder cancerSemantic proximity
Immunotherapy in Bladder Cancer: A Systematic Review of Clinical Trials and Therapeutic AdvancesSemantic proximity
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity
Differential effects of BCG-Russia and BCG-TICE on trained immunity: potential implications for bladder cancer immunotherapySemantic proximity
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infectionsSemantic proximity
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.Semantic proximity
Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder CancerSemantic proximity
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.Semantic proximity
Management of Non-Muscle-invasive Bladder Cancer: Quality of Clinical Practice Guidelines and Variations in RecommendationsSemantic proximity
The Potential Antitumor Effects of Combining Intravesical Therapy with Recombinant Bacillus Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder CancerSemantic proximity
Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.Semantic proximity
Select a neighboring publication to make it the new centre.